Efficacy and Safety of Immunotherapy Combined With Neoadjuvant Chemotherapy in Patients With Locally Advanced HPV (-) Head and Neck Squamous Cell Carcinoma: a Phase II Clinical Trial

Clinical trial NCT04929067 · UNKNOWN

Trial details

NCT number: NCT04929067
Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Efficacy and Safety of Immunotherapy Combined With Neoadjuvant Chemotherapy in Patients With Locally Advanced HPV (-) HNSCC

Start date: 2021-08-01
Primary completion: 2023-04-01
Enrollment: 39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.